A shadow economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.
Several professionals said the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Content Elimination
According to TikTok, the service has taken down problematic content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at residence.
After moments of entering one group, a seller posted contact information, where most purchases occur. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.
Product Details and Costs
Within these groups, messages show black plastic parcels with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially significant medical dangers”.
